L. Martin

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

J. Ajani, C. Reed, K. Bhalla, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)

P. Rodrigues, J. Banales, B. Mínguez, 2020, Cancers.

LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

C. Borel, J. Thariat, C. Sire, 2021, Annals of Oncology.

VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA.

Xiaobai Li, T. Bekaii-Saab, M. Zalupski, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.

M. Mehta, D. Petereit, S. Adak, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.